Ryman Healthcare

Ryman Healthcare, based in New Zealand, reported approximately 10,675,000 kg CO2e in total emissions for 2025. This included 4,763,000 kg CO2e from Scope 1 emissions, 2,862,000 kg CO2e from Scope 2 market-based emissions, and 3,050,000 kg CO2e from Scope 3 emissions.

In 2024, the company's total emissions were approximately 17,314,000 kg CO2e, with Scope 1 emissions at 4,663,000 kg CO2e, Scope 2 market-based emissions at 8,234,000 kg CO2e, and Scope 3 emissions at 4,417,000 kg CO2e. For 2021, the company disclosed Scope 1 emissions of 4,317,000 kg CO2e, Scope 2 emissions of 8,333,000 kg CO2e, and Scope 3 emissions including 469,000 kg CO2e from business travel and 3,131,000 kg CO2e from waste generated in operations.

Ryman Healthcare has set Science Based Targets initiative (SBTi) commitments. The company aims to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2021 as the base year. Additionally, Ryman Healthcare is committed to ensuring that 75.5% of its suppliers by spend, covering purchased goods and services, capital goods, and waste generated in operations, will have science-based targets by FY2028.